BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: novice investor who wrote (34)	8/19/1997 8:32:00 PM
From: geewiz	of 534

Hi NI, I spoke to Peggy Miller this afternoon at IR. The registration to sell an additional 3 million shares relates to the sale in June which is discussed in the most recent release. This is not an additional 3 million shares. She also said the company is not going it alone in distribution, management will team up with any distributor qualified to represent the product. I got a sense that they expect a lot more from a distributor that someone selling cases of needles. As for the number of full time reps: 5 full time sales reps, one flex rep who visits customers to follow up on applications and 2 per diem nurses who train in applications. She told me the phase II trials are for a vaccine that is used for herpes and HIV infections. It is presently being tested at 8 sites. Some contract should come from it someday........ I forgot to ask about the specific revenue from the WMT deal! Interesting site on the HMS Beagle today: vaccines.com If only BJCT would take out an ad on that page! best, art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next